Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 14, 2006

Johns Hopkins Bayview Proteomics Center Picks Ludesi for Image Analysis Processing

  • The Johns Hopkins Bayview Proteomics Center selected Ludesi for its gel image analysis obtained from 2-D gel electrophoresis. "Our technology is uncovering crucial information in 2-D gel images that conventional 2-D gel software doesn't find because of analysis errors,” comments Ola Forsstrom-Olsson, CEO at Ludesi.

    The research at Johns Hopkins Bayview Proteomics Center focuses on the use and optimization of proteomic analysis of tissue and serum for the development of treatments and diagnostics for heart disease.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »